0001209191-20-046213.txt : 20200811
0001209191-20-046213.hdr.sgml : 20200811
20200811175435
ACCESSION NUMBER: 0001209191-20-046213
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200810
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norrett Kevin
CENTRAL INDEX KEY: 0001819690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 201093622
MAIL ADDRESS:
STREET 1: C/O SIERRA ONCOLOGY, INC.
STREET 2: 2150 885 WEST GEORGIA ST.
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-10
0
0001290149
Sierra Oncology, Inc.
SRRA
0001819690
Norrett Kevin
C/O SIERRA ONCOLOGY, INC.
2150 885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Business Officer
Stock option (right to buy)
12.05
2020-08-10
4
A
0
100000
0.00
A
2030-08-10
Common Stock
100000
100000
D
The option vests as to 25% of the total shares on August 10, 2021, and then the remaining shares vest in equal monthly installments over the following 36 months, with 100% of the total shares vested on August 10, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Sukhi Jagpal, as attorney-in-fact for Kevin Norrett
2020-08-11